What are the next steps in managing a 14-month-old child with a history of milk allergy, who accidentally ingested milk, was given an EpiPen (epinephrine) by the mother, and presents with tachycardia, normal oxygen saturation, and tachypnea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Milk-Induced Anaphylaxis in a 14-Month-Old Child

The 14-month-old child with milk-induced anaphylaxis who has already received epinephrine requires continued observation, a second dose of epinephrine if symptoms persist or worsen, supplemental oxygen if needed, and IV fluid administration for tachycardia. 1

Initial Assessment and Management

  • Evaluate the child's airway, breathing, and circulation with particular attention to the vital signs (tachycardia at 156, respiratory rate of 36, oxygen saturation 97%) 1
  • Place the child in a recumbent position with legs elevated if tolerated to prevent orthostatic hypotension and improve circulation 1
  • Establish IV access for fluid administration with normal saline (crystalloid) at 20-30 mL/kg in the first hour to address tachycardia 1
  • Monitor vital signs continuously, particularly heart rate, respiratory rate, and oxygen saturation 1, 2
  • Administer a second dose of epinephrine (0.15 mg via autoinjector or 0.01 mg/kg of 1:1000 solution IM in the anterolateral thigh) if symptoms persist or worsen after 5-15 minutes 1

Adjunctive Treatments

  • Provide supplemental oxygen if respiratory distress worsens or oxygen saturation drops below 92% 1, 3
  • Consider nebulized albuterol (1.5 mL) if wheezing or bronchospasm is present 1
  • Administer H1-antihistamine such as diphenhydramine (1-2 mg/kg, maximum 50 mg) as adjunctive therapy, not as a replacement for epinephrine 1
  • Consider corticosteroids (e.g., methylprednisolone 1 mg/kg IV) to potentially reduce the risk of prolonged or biphasic reactions, although evidence for this is limited 1, 4

Observation Period

  • Observe the child for at least 4-6 hours after the initial reaction, as biphasic reactions can occur in 1-20% of anaphylaxis cases 1, 5
  • Monitor closely for signs of deterioration including increased respiratory distress, declining oxygen saturation, worsening tachycardia, or hypotension 1, 2
  • Be prepared to administer additional epinephrine if symptoms recur during the observation period 1

Discharge Planning

  • Prescribe two doses of epinephrine autoinjector (0.15 mg for a child weighing less than 25 kg) 1, 3
  • Create a written anaphylaxis emergency action plan that includes recognition of symptoms and instructions for epinephrine administration 1, 3
  • Provide education to parents about proper technique for epinephrine autoinjector use, including demonstration and practice with a trainer device 1, 3
  • Arrange follow-up with an allergist for comprehensive evaluation and management of milk allergy 1, 3
  • Educate parents about strict milk avoidance, including hidden sources of milk in foods 1

Important Considerations and Pitfalls

  • Do not delay administering a second dose of epinephrine if symptoms persist or worsen, as delayed administration is associated with increased mortality 1, 3
  • Be aware that epinephrine can cause transient pallor, tremor, anxiety, and palpitations, which are expected pharmacologic effects and not reasons to withhold treatment 1
  • Avoid administering epinephrine in incorrect locations (e.g., digits, hands, feet, or buttocks) as this can lead to tissue necrosis or infections 6
  • Remember that antihistamines and corticosteroids should not delay epinephrine administration and do not prevent respiratory or cardiovascular compromise 4, 7
  • Consider that infants and young children may have atypical presentations of anaphylaxis, with respiratory symptoms often predominating over cutaneous manifestations 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Anaphylaxis in Patients with History of Hazelnut Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Emergency medicine updates: Anaphylaxis.

The American journal of emergency medicine, 2021

Research

Emergency treatment of anaphylaxis in infants and children.

Paediatrics & child health, 2011

Research

Anaphylaxis: Emergency Department Treatment.

Emergency medicine clinics of North America, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.